Federal Register #2026-20114

DEA proposes centralized reporting collection for suspicious controlled-substance orders

The Drug Enforcement Administration is proposing a centralized information collection for reporting suspicious orders of controlled substances. - Government buyer: U.S. Department of Justice (DOJ), Drug Enforcement Administration (DEA), Diversion Control Division. - Opportunity type: Proposed information collection, not a procurement for products or services. The notice requests Office of Management and Budget (OMB) review and approval under the Paperwork Reduction Act. - Purpose and requirement: Support a centralized database for reports of suspicious orders of controlled substances. The collection has no form number and is identified as OMB Control Number 1117-0056. - Respondents and estimated burden: Businesses and other for-profit entities; 178 respondents, 739,429 annual responses, approximately 0.0167 hours per response, and 12,324 total annual burden hours. - OEMs, vendors, products, and services: None identified.

Description

The Department of Justice, through the Drug Enforcement Administration, is requesting review and approval of a proposed new information collection under the Paperwork Reduction Act of 1995. The collection would establish a centralized database for reporting all suspicious orders of controlled substances. The affected public is businesses and other for-profit entities, and the notice estimates 178 respondents and 12,324 annual burden hours. Comments are accepted through November 2, 2026.

View original listing